Update date
28 Feb 2026
Shareable Research Card
Alphega Innovations Corp Return On Equity
This metric view shows Alphega Innovations Corp return on equity history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q1 2026
- Latest reported value
- 60%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 28 Feb 2026
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q1 2026.
- Latest reported value on this page: 60%.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Return On Equity
Latest reported return on equity: 60%. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q1 2026
SEC-backed company facts were refreshed from filings filed on 14 Apr 2026.
Benchmark Context
How Return On Equity compares with peers
Alphega Innovations Corp is outside the visible top 120 companies for return on equity in the current sample.
Compared with
Compared with 120 companies reporting return on equity in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Return On Equity is down about 85% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2015 to 31 Mar 2026.
- Nearby companies in this sample: Savara Inc and Moleculin Biotech, Inc..
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Alphega Innovations Corp: Return On Equity
Latest period: Q1 2026. Period end: 28 Feb 2026. Units: %. Frequency: quarterly and annual.
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Metric Snapshot
- Latest value
- 60%
- Coverage range
- 31 Aug 2024 - 28 Feb 2026
- Fact rows
- 5
What This Metric Tells You
- Shows reported return on equity over 31 Aug 2024 - 28 Feb 2026.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 5 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Savara Inc (svra) | 58391% | Quarter - 31 Mar 2026 | Open Savara Inc Return On Equity |
| 2 | Moleculin Biotech, Inc. (mbrx) | 51267% | Quarter - 31 Mar 2026 | Open Moleculin Biotech, Inc. Return On Equity |
| 3 | Bionik Laboratories Corp. | 46191% | Quarter - 31 Mar 2023 | Open Bionik Laboratories Corp. Return On Equity |
| 4 | Athenex, Inc. | 25553% | Year - 31 Dec 2022 | Open Athenex, Inc. Return On Equity |
| 5 | Corvex, Inc. (move) | 24059% | Year - 31 Dec 2025 | Open Corvex, Inc. Return On Equity |
| 6 | Wenyuan Group Corp. (wygc) | 21298% | Year - 31 Dec 2025 | Open Wenyuan Group Corp. Return On Equity |
Metric Details
- Metric
- Return On Equity (ROE)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 31 Aug 2024 - 28 Feb 2026
- Facts on this page
- 5
- Metric definition
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- SEC metric endpoint
- Open SEC company concept
Metric identity
2 facts
Metric coverage
4 facts
How to read it
1 fact
SEC evidence
1 fact
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Alphega Innovations Corp Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q1 2026 | 60% | -349% | -85% | 01 Dec 2025 | 28 Feb 2026 |
| Q3 2025 | 59% | -41% | -41% | 01 Jun 2025 | 31 Aug 2025 |
| Q1 2025 | 409% | 01 Dec 2024 | 28 Feb 2025 | ||
| Q3 2024 | 100% | 24 Jul 2024 | 31 Aug 2024 |
Alphega Innovations Corp Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | 178% | 01 Dec 2024 | 30 Nov 2025 |
* indicates a reported value that failed the local validity check.